| Year |
Citation |
Score |
| 2018 |
Passey C, Suryawanshi S, Sanghavi K, Gupta M. Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies. The Aaps Journal. 20: 35. PMID 29484520 DOI: 10.1208/S12248-018-0194-9 |
0.306 |
|
| 2017 |
Passey C, Sheng J, Mora J, Tendolkar A, Robbins M, Dodge R, Roy A, Bello A, Gupta M. The Clinical Pharmacology of Elotuzumab. Clinical Pharmacokinetics. PMID 28779463 DOI: 10.1007/S40262-017-0585-6 |
0.33 |
|
| 2017 |
Passey C, Mora J, Dodge R, Gibiansky L, Sheng J, Roy A, Bello A, Gupta M. An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of Elotuzumab. The Aaps Journal. PMID 28070715 DOI: 10.1208/S12248-016-0033-9 |
0.322 |
|
| 2016 |
Gibiansky L, Passey C, Roy A, Bello A, Gupta M. Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma. Journal of Pharmacokinetics and Pharmacodynamics. PMID 26993283 DOI: 10.1007/S10928-016-9469-X |
0.326 |
|
| 2012 |
Passey C, Birnbaum AK, Brundage RC, Schladt DP, Oetting WS, Leduc RE, Israni AK, Guan W, Matas AJ, Jacobson PA. Validation of tacrolimus equation to predict troughs using genetic and clinical factors. Pharmacogenomics. 13: 1141-7. PMID 22909204 DOI: 10.2217/Pgs.12.98 |
0.473 |
|
| 2011 |
Passey C, Birnbaum AK, Brundage RC, Oetting WS, Israni AK, Jacobson PA. Dosing equation for tacrolimus using genetic variants and clinical factors. British Journal of Clinical Pharmacology. 72: 948-57. PMID 21671989 DOI: 10.1111/J.1365-2125.2011.04039.X |
0.471 |
|
| Show low-probability matches. |